DA32 Life Science Tech Acquisition Stock (NASDAQ:DALS)
Previous Close
$10.32
52W Range
$9.68 - $11.22
50D Avg
$10.27
200D Avg
$10.09
Market Cap
$264.19M
Avg Vol (3M)
$29.06K
Beta
-
Div Yield
-
DALS Company Profile
DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.
Industry
Shell Companies
Sector
Financial Services
Exchange
NASDAQ
ADR
-
Country
US
Employees
-
IPO Date
Jul 28, 2021
Website
-